Detailed information for compound 175108

Basic information

Technical information
  • TDR Targets ID: 175108
  • Name: ethyl 2-[1-[(2S)-2-[(4-carbamimidoylbenzoyl)a mino]-3-(4-hydroxyphenyl)propanoyl]piperidin- 4-yl]oxyacetate
  • MW: 496.555 | Formula: C26H32N4O6
  • H donors: 3 H acceptors: 4 LogP: 2.02 Rotable bonds: 13
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCOC(=O)COC1CCN(CC1)C(=O)[C@@H](NC(=O)c1ccc(cc1)C(=N)N)Cc1ccc(cc1)O
  • InChi: 1S/C26H32N4O6/c1-2-35-23(32)16-36-21-11-13-30(14-12-21)26(34)22(15-17-3-9-20(31)10-4-17)29-25(33)19-7-5-18(6-8-19)24(27)28/h3-10,21-22,31H,2,11-16H2,1H3,(H3,27,28)(H,29,33)/t22-/m0/s1
  • InChiKey: KLVKCAIZZUINTK-QFIPXVFZSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • ethyl 2-[[1-[(2S)-2-[(4-carbamimidoylbenzoyl)amino]-3-(4-hydroxyphenyl)propanoyl]-4-piperidyl]oxy]acetate
  • 2-[[1-[(2S)-2-[[(4-carbamimidoylphenyl)-oxomethyl]amino]-3-(4-hydroxyphenyl)-1-oxopropyl]-4-piperidinyl]oxy]acetic acid ethyl ester
  • ethyl 2-[1-[(2S)-2-[(4-carbamimidoylphenyl)carbonylamino]-3-(4-hydroxyphenyl)propanoyl]piperidin-4-yl]oxyethanoate
  • 2-[[1-[(2S)-2-[(4-amidinobenzoyl)amino]-3-(4-hydroxyphenyl)propanoyl]-4-piperidyl]oxy]acetic acid ethyl ester

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) Starlite/ChEMBL References
Homo sapiens integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Brugia malayi Integrin beta pat-3 precursor Get druggable targets OG5_127959 All targets in OG5_127959
Schistosoma mansoni integrin alpha Get druggable targets OG5_129341 All targets in OG5_129341
Echinococcus multilocularis integrin beta 2 Get druggable targets OG5_127959 All targets in OG5_127959
Loa Loa (eye worm) integrin alpha pat-2 Get druggable targets OG5_129341 All targets in OG5_129341
Schistosoma mansoni integrin beta subunit Get druggable targets OG5_127959 All targets in OG5_127959
Schistosoma japonicum IPR013513,Integrin alpha chain, C-terminal cytoplasmic region,domain-containing Get druggable targets OG5_129341 All targets in OG5_129341
Schistosoma japonicum ko:K06476 integrin alpha 2B, putative Get druggable targets OG5_129341 All targets in OG5_129341
Brugia malayi Integrin alpha pat-2 precursor Get druggable targets OG5_129341 All targets in OG5_129341
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_129341 All targets in OG5_129341
Schistosoma japonicum Integrin beta-PS precursor, putative Get druggable targets OG5_127959 All targets in OG5_127959
Echinococcus multilocularis integrin alpha 3 Get druggable targets OG5_129341 All targets in OG5_129341
Schistosoma japonicum Integrin beta-3 precursor, putative Get druggable targets OG5_127959 All targets in OG5_127959
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_129341 All targets in OG5_129341
Echinococcus granulosus integrin alpha 3 Get druggable targets OG5_129341 All targets in OG5_129341
Schistosoma japonicum ko:K06464 integrin beta 2, putative Get druggable targets OG5_127959 All targets in OG5_127959
Loa Loa (eye worm) integrin beta-2 Get druggable targets OG5_127959 All targets in OG5_127959
Echinococcus granulosus integrin beta 2 Get druggable targets OG5_127959 All targets in OG5_127959

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis PIKK family atypical protein kinase 0.1189 0.5564 0.5402
Trichomonas vaginalis PIKK family atypical protein kinase 0.1073 0.492 0.4735
Entamoeba histolytica FKBP-rapamycin associated protein (FRAP), putative 0.199 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.1074 0.4929 0.4745
Trichomonas vaginalis PIKK family atypical protein kinase 0.1583 0.7745 0.7663
Trypanosoma cruzi target of rapamycin kinase 3 0.1584 0.7754 0.7672
Toxoplasma gondii non-specific serine/threonine protein kinase 0.0419 0.13 0.039
Trichomonas vaginalis PIKK family atypical protein kinase 0.1177 0.5498 0.5335
Trichomonas vaginalis PIKK family atypical protein kinase 0.0376 0.1062 0.0737
Trichomonas vaginalis PIKK family atypical protein kinase 0.1073 0.492 0.4735
Trichomonas vaginalis PIKK family atypical protein kinase 0.0667 0.2674 0.2407
Trichomonas vaginalis PIKK family atypical protein kinase 0.0376 0.1062 0.0737
Brugia malayi FAT domain containing protein 0.0291 0.0589 0.0589
Loa Loa (eye worm) hypothetical protein 0.0291 0.0589 0.0247
Trichomonas vaginalis PIKK family atypical protein kinase 0.148 0.7175 0.7073
Trichomonas vaginalis PIKK family atypical protein kinase 0.1074 0.4929 0.4745
Leishmania major target of rapamycin (TOR) kinase 2, putative 0.199 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.148 0.7175 0.7073
Schistosoma mansoni fkbp-rapamycin associated protein 0.0376 0.1062 0.1062
Echinococcus granulosus serine:threonine protein kinase SMG1 0.0376 0.1062 0.0562
Echinococcus granulosus PIK kinase FAT and Armadillo domain containing protein 0.0291 0.0589 0.0063
Trichomonas vaginalis PIKK family atypical protein kinase 0.1583 0.7745 0.7663
Trichomonas vaginalis PIKK family atypical protein kinase 0.0667 0.2674 0.2407
Trichomonas vaginalis PIKK family atypical protein kinase 0.0667 0.2674 0.2407
Trichomonas vaginalis PIKK family atypical protein kinase 0.0534 0.1935 0.1641
Echinococcus granulosus FKBP12 rapamycin complex associated protein 0.199 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.1583 0.7745 0.7663
Echinococcus granulosus serine protein kinase ATM 0.0376 0.1062 0.0562
Trypanosoma brucei Phosphatidylinositol 3-kinase tor1 0.199 1 1
Echinococcus granulosus phosphatidylinositol 3 and 4 kinase 0.0667 0.2674 0.2264
Trypanosoma cruzi phosphatidylinositol 3-related kinase, putative 0.0667 0.2674 0.2407
Trypanosoma cruzi phosphatidylinositol 3-kinase, putative 0.0376 0.1062 0.0737
Loa Loa (eye worm) phosphatidylinositol 3 0.0667 0.2674 0.2407
Schistosoma mansoni phosphatidylinositol 3-and 4-kinase 0.0667 0.2674 0.2674
Trichomonas vaginalis PIKK family atypical protein kinase 0.1189 0.5564 0.5402
Trichomonas vaginalis PIKK family atypical protein kinase 0.0667 0.2674 0.2407
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor1 0.199 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0376 0.1062 0.0737
Trypanosoma brucei phosphatidylinositol 4-kinase, putative 0.199 1 1
Trypanosoma brucei FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative 0.0826 0.3555 0.279
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0376 0.1062 0.1062
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0667 0.2674 0.2674
Schistosoma mansoni ataxia telangiectasia mutated (atm)-related 0.199 1 1
Brugia malayi Integrin beta pat-3 precursor 0.0378 0.1072 0.1072
Loa Loa (eye worm) phosphatidylinositol 3 0.199 1 1
Leishmania major target of rapamycin kinase (TOR) kinase 3 0.1584 0.7754 0.6934
Echinococcus multilocularis FKBP12 rapamycin complex associated protein 0.199 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0419 0.13 0.0984
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0376 0.1062 0.1062
Trypanosoma cruzi phosphatidylinositol 3-related kinase, putative 0.0667 0.2674 0.2407
Echinococcus multilocularis serine protein kinase ATM 0.0376 0.1062 0.0562
Trichomonas vaginalis PIKK family atypical protein kinase 0.199 1 1
Loa Loa (eye worm) integrin beta-2 0.0378 0.1072 0.0748
Trichomonas vaginalis PIKK family atypical protein kinase 0.1292 0.6133 0.5992
Trypanosoma brucei phosphatidylinositol 3-related kinase, putative 0.0667 0.2674 0.1803
Leishmania major target of rapamycin (TOR) kinase 1, putative 0.199 1 1
Echinococcus multilocularis phosphatidylinositol 3 and 4 kinase 0.0667 0.2674 0.2264
Trichomonas vaginalis PIKK family atypical protein kinase 0.148 0.7175 0.7073
Schistosoma mansoni hypothetical protein 0.0291 0.0589 0.0589
Toxoplasma gondii target of rapamycin (TOR), putative 0.148 0.7175 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.1189 0.5564 0.5402
Loa Loa (eye worm) hypothetical protein 0.0419 0.13 0.0984
Trichomonas vaginalis PIKK family atypical protein kinase 0.1177 0.5498 0.5335
Trichomonas vaginalis PIKK family atypical protein kinase 0.1073 0.492 0.4735
Trichomonas vaginalis PIKK family atypical protein kinase 0.148 0.7175 0.7073
Trypanosoma brucei target of rapamycin kinase 3, putative 0.1584 0.7754 0.7487
Schistosoma mansoni integrin beta subunit 0.0223 0.0211 0.0211
Trichomonas vaginalis PIKK family atypical protein kinase 0.0667 0.2674 0.2407
Schistosoma mansoni ataxia telangiectasia mutated (atm) 0.0376 0.1062 0.1062
Trichomonas vaginalis PIKK family atypical protein kinase 0.1335 0.6371 0.6239
Trichomonas vaginalis PIKK family atypical protein kinase 0.148 0.7175 0.7073
Echinococcus multilocularis PIK kinase, FAT and Armadillo domain containing protein 0.0291 0.0589 0.0063
Trichomonas vaginalis PIKK family atypical protein kinase 0.1074 0.4929 0.4745
Trichomonas vaginalis conserved hypothetical protein 0.0291 0.0589 0.0247
Trichomonas vaginalis PIKK family atypical protein kinase 0.1583 0.7745 0.7663
Trichomonas vaginalis PIKK family atypical protein kinase 0.148 0.7175 0.7073
Echinococcus multilocularis serine:threonine protein kinase SMG1 0.0376 0.1062 0.0562
Trypanosoma cruzi phosphatidylinositol kinase related protein, putative 0.0376 0.1062 0.0737
Trichomonas vaginalis PIKK family atypical protein kinase 0.148 0.7175 0.7073
Trichomonas vaginalis PIKK family atypical protein kinase 0.1074 0.4929 0.4745
Trichomonas vaginalis PIKK family atypical protein kinase 0.199 1 1
Trypanosoma brucei phosphatidylinositol 3-kinase tor, putative 0.0941 0.419 0.35
Trichomonas vaginalis PIKK family atypical protein kinase 0.1583 0.7745 0.7663
Trichomonas vaginalis PIKK family atypical protein kinase 0.199 1 1
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor2 0.199 1 1
Giardia lamblia GTOR 0.199 1 0.5
Entamoeba histolytica phosphatidylinositol3-kinaseTor2, putative 0.199 1 1
Loa Loa (eye worm) hypothetical protein 0.0406 0.1223 0.0904
Loa Loa (eye worm) integrin alpha pat-2 0.0285 0.0554 0.0211
Trypanosoma brucei phosphatidylinositol 3-kinase, putative 0.0667 0.2674 0.1803
Trichomonas vaginalis PIKK family atypical protein kinase 0.1699 0.8388 0.833
Loa Loa (eye worm) hypothetical protein 0.0376 0.1062 0.0737

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 51 nM Inhibition of FG binding to alpha IIb beta3 integrin ChEMBL. 8759635
IC50 (binding) = 51 nM Inhibition of FG binding to alpha IIb beta3 integrin ChEMBL. 8759635
IC50 (functional) = 63 nM Inhibition of platelet aggregation in human platelet rich plasma(h-PRP) induced by adenosine 5-diphosphate(ADP) ChEMBL. 8759635
IC50 (functional) = 63 nM Inhibition of platelet aggregation in human platelet rich plasma(h-PRP) induced by adenosine 5-diphosphate(ADP) ChEMBL. 8759635
ID50 (functional) = 6.9 mg kg-1 Inhibition of platelet aggregation of human platelet rich plasma(h-PRP) induced by adenosine 5-diphosphate(ADP).(oral activity in mice) ChEMBL. 8759635
ID50 (functional) = 6.9 mg kg-1 Inhibition of platelet aggregation of human platelet rich plasma(h-PRP) induced by adenosine 5-diphosphate(ADP).(oral activity in mice) ChEMBL. 8759635

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23 8759635

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.